Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $60.0 million.

  • NeuroPace's Cash & Current Investments rose 560.27% to $60.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.0 million, marking a year-over-year increase of 560.27%. This contributed to the annual value of $52.8 million for FY2024, which is 2061.43% down from last year.
  • As of Q3 2025, NeuroPace's Cash & Current Investments stood at $60.0 million, which was up 560.27% from $62.1 million recorded in Q2 2025.
  • NeuroPace's Cash & Current Investments' 5-year high stood at $127.9 million during Q2 2021, with a 5-year trough of $30.5 million in Q1 2021.
  • In the last 5 years, NeuroPace's Cash & Current Investments had a median value of $66.3 million in 2025 and averaged $75.1 million.
  • As far as peak fluctuations go, NeuroPace's Cash & Current Investments skyrocketed by 117927.79% in 2021, and later crashed by 3446.57% in 2023.
  • Over the past 5 years, NeuroPace's Cash & Current Investments (Quarter) stood at $115.6 million in 2021, then crashed by 33.03% to $77.4 million in 2022, then dropped by 14.15% to $66.5 million in 2023, then decreased by 20.61% to $52.8 million in 2024, then increased by 13.76% to $60.0 million in 2025.
  • Its Cash & Current Investments stands at $60.0 million for Q3 2025, versus $62.1 million for Q2 2025 and $66.3 million for Q1 2025.